Carlos Honrado joined the Medical Devices group at INL in 2021 as a Research Fellow to pursue his research interests in developing microfluidic devices for biomedical use. In 2022, he was awarded a Marie Skłodowska-Curie Actions Individual Fellowship to work on the EVOLVE project, focused on the isolation and analysis of extracellular vesicles in the therapeutic and clinical context of endometrial cancer. Since 2024, he is a Research Scientist at INL, being the Technical Principal Investigator of the SENSOPAD project (Horizon 2020), focusing on developing microfluidic platforms to diagnose endometriosis at an early stage using menstrual fluid as a novel liquid biopsy type. 

Carlos obtained his MSc in Biomedical Engineering from the University of Minho in 2014, with his thesis being completed during an ERASMUS exchange period at the University of Southeastern Norway. He obtained his PhD from the University of Southampton in 2018, focusing on label-free single particle analysis and separation, and performed further research on this field as a Research Associate at the University of Virginia (2018 to 2021). Since 2014, he has authored 27 peer-reviewed publications, 13 of which as first author (h-index=17), and presented at multiple international conferences. He has participated in science outreach events for research dissemination and entrepreneurship activities. He also has one granted patent and four others filed.